Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

GPA Patient Carries NORD Banner to Top of Mt. Everest

Carol Patton  |  Issue: December 2015  |  December 16, 2015

On the summit of Mt.  Everest, Ms. Abbott displays a banner for the National Organization of Rare Disorders.

On the summit of Mt.
Everest, Ms. Abbott displays a banner for the National Organization of Rare Disorders.

On May 23, 2010, Cindy Abbott was standing on top of the world. She had spent the past 51 days climbing Mount Everest, the tallest mountain in the world, and had finally reached the summit.

“I was very anxious to get off and get back down,” she says, adding that the summit is about the size of a pool table. “Most of the accidents happen on the way down. So I sat down, took my medication, got my shot holding the National Organization of Rare Disorders (NORD) banner, put my glove back on and headed right down. The storm hit when we started down.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At this high altitude, known as the Death Zone, the oxygen level is so low that the body begins to shut down. Even the most acclimatized mountain climbers can’t spend more than 48 hours above 26,000 feet. (The bottom of the Earth’s stratosphere is 33,000 feet.)

Under conditions with 40-mile-per-hour winds and sub-zero temperatures, both of Ms. Abbott’s corneas froze. For all practical purposes, she was blind, although she could distinguish between light and dark, which enabled her to differentiate rock from sky or snow. Her fingertips and cheeks were frostbitten.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Ms. Abbott and the other four climbers in her group used one rope to rappel down 3,000 feet to prevent them from plunging off the mountain’s edge.

“The storm lasted until we got down to Camp 4 and lasted through the night,” Ms. Abbott says, adding it took nearly seven hours to reach the camp. “I was the 40th American female to summit Mt. Everest. I was 51 years old.”

GPA Won’t Define Her

Dr. Dellaripa

Dr. Dellaripa

Although impressive by any measure, that’s not Ms. Abbott’s biggest accomplishment. Hardly. Ms. Abbott suffers from granulomatosis with polyangiitis (GPA), a rare blood vessel disease that affects roughly three out of every 100,000 people, according to the American College of Rheumatology.1 GPA often attacks the sinuses, lungs and kidneys, and can lead to kidney failure.

Since her 2007 diagnosis, Ms. Abbott continues to defy the odds—and not just clinically. Although her condition has been stable for seven years, it has left her functionally blind in her left eye, caused a series of transient ischemic attacks and prompted multiple sinus and eye surgeries. However, she refuses to let the illness define her or limit her active lifestyle. She continues climbing mountains, and earlier this year, finished Alaska’s 1,000 mile Iditarod race. What motivates her? No one knows, not even Ms. Abbot, who claims she’s simply experiencing life.

Toughest Challenge of All

Although some research has been conducted on GPA, the cause is still unknown.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsProfessional TopicsProfiles Tagged with:GPAgranulomatosis with polyangiitisNational Organization of Rare DisordersNORDProfile

Related Articles
    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    Case Report: GPA or IgG4-Related Disease in an 11-Year-Old Girl?

    April 7, 2023

    Granulomatosis with polyangiitis (GPA) is a type of anti-neutrophil cytoplasmic antibody (ANCA) associated small vessel vasculitis that typically affects the kidneys, lungs and sinuses.1 Due to an overlap in signs and symptoms, GPA may initially be difficult to distinguish from IgG4-related disease, another condition that can affect multiple tissues and has variable presentations. Further complicating…

    Case Report: A COVID-19 Mimic

    September 11, 2020

    A 67–year-old white woman with primary Raynaud’s phenomenon presented following a week of progressively worsening shortness of breath, dry cough and generalized malaise. An avid tennis player, she first noticed dyspnea while playing, but a few days later grew short of breath even at rest. She went to an urgent care center, where a computed…

    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences